<div id="readability-page-1"><div><p><span>Sarin Aradhana, Chief Financial Officer of Astrazeneca Plc [AZN], filed a Form 144 on November 12, 2025 with the Securities and Exchange Commission proposing to sell restricted securities:</span></p><div><table><tbody><tr><td><span>Approximate Date Of Sale</span></td><td><span>11/12/25</span></td></tr><tr><td><span>Shares</span></td><td><span>15,000</span></td></tr><tr><td><span>Broker</span></td><td><span>Morgan Stanley Smith Barney LLC</span></td></tr></tbody></table></div><p><span>Prior to the sale of restricted stock, owners must file a Form 144 with the SEC.  Upon submission of the filing to the SEC the owner is permitted to sell the shares, or any fraction thereof, within 90 days.</span></p><p><span>For a free trial, or to learn more about our insider trading analysis and data services, please visit http://www.washingtonservice.com or contact us at (301) 913-5100 or send an email to info@washingtonservice.com.</span></p><p><span>Founded in 1970, The Washington Service provides securities professionals with financial, economic and public policy research and data.</span></p><span> </span></div></div>

<p>Sarin Aradhana, CFO of Astrazeneca Plc [AZN], filed a Form 144 with the SEC on November 12, 2025, to sell 15,000 shares of restricted securities. The filing allows the sale of shares within 90 days, facilitated by Morgan Stanley Smith Barney LLC. This is a standard procedure for selling restricted stock.</p>

CFO Sarin Files To Sell 15,000 Of Astrazeneca Plc [AZN]